ACCESS-AP

Summary

This study focuses on individuals who have been diagnosed with pancreatitis and consume alcohol. The purpose of the study is to examine health behaviors (including alcohol consumption, diet and smoking) that may contribute to the development of acute pancreatitis. Researchers aim to determine whether recent increase in alcohol consumption precipitates an attack of pancreatitis and whether the impact of alcohol is different for individuals who drink or smoke regularly. Participants will complete interviews about health behaviors, as well as provide blood and urine samples. Another purpose of the study is to learn whether a biomarker test may help determine who is at higher risk for recurrence of pancreatitis. A biomarker is a biological molecule found in blood, urine, other body fluids or tissues that may be a sign of a condition or disease.


Inclusion Criteria

  • Aged 18-75 years at the time of eligibility assessment
  • Currently hospitalized with Acute Pancreatitis (AP) per Revised Atlanta Classification, which requires two of the following evidence of pancreatitis:
Show more

Study Location(s)

Cedars-Sinai Cancer at SOCC

More about this Clinical Trial

Full Title

IIT2020-05-JEON-ACCESS: A Case-CrossovEr Study deSign to inform tailored interventions to prevent disease progression in Acute Pancreatitis

Details
Disease Type/Condition

Alcoholic pancreatitis, Pancreatic Diseases

Principal Investigator

Jeon, Christie

Co-Investigators

Stephen Pandol

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

STUDY00000364

ClinicalTrials.gov ID

NCT04743323

Key Eligibility
ClinicalTrials.gov

Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?

Details
Disease Type/Condition

Alcoholic pancreatitis, Pancreatic Diseases

Principal Investigator

Jeon, Christie

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

IIT2020-05-JEON-ACCESS

ClinicalTrials.gov ID

NCT04743323

Key Eligibility
ClinicalTrials.gov

Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?